Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Ann Oncol. 2023 Jan;34(1):48-60. doi: 10.1016/j.annonc.2022.09.158. Epub 2022 Sep 29.
Ann Oncol. 2023.
PMID: 36182023
Free article.
Review.
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance.
Yap C, Rekowski J, Ursino M, Solovyeva O, Patel D, Dimairo M, Weir CJ, Chan AW, Jaki T, Mander A, Evans TRJ, Peck R, Hayward KS, Calvert M, Rantell KR, Lee S, Kightley A, Hopewell S, Ashby D, Garrett-Mayer E, Isaacs J, Golub R, Kholmanskikh O, Richards DP, Boix O, Matcham J, Seymour L, Ivy SP, Marshall LV, Hommais A, Liu R, Tanaka Y, Berlin J, Espinasse A, de Bono J.
Yap C, et al. Among authors: kholmanskikh o.
BMJ. 2023 Oct 20;383:e076386. doi: 10.1136/bmj-2023-076386.
BMJ. 2023.
PMID: 37863491
No abstract available.
Item in Clipboard
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance.
Yap C, Solovyeva O, de Bono J, Rekowski J, Patel D, Jaki T, Mander A, Evans TRJ, Peck R, Hayward KS, Hopewell S, Ursino M, Rantell KR, Calvert M, Lee S, Kightley A, Ashby D, Chan AW, Garrett-Mayer E, Isaacs JD, Golub R, Kholmanskikh O, Richards D, Boix O, Matcham J, Seymour L, Ivy SP, Marshall LV, Hommais A, Liu R, Tanaka Y, Berlin J, Espinasse A, Dimairo M, Weir CJ.
Yap C, et al. Among authors: kholmanskikh o.
BMJ. 2023 Oct 20;383:e076387. doi: 10.1136/bmj-2023-076387.
BMJ. 2023.
PMID: 37863501
Free PMC article.
Item in Clipboard
Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting.
Vermaelen K, Waeytens A, Kholmanskikh O, Van den Bulcke M, Van Valckenborgh E.
Vermaelen K, et al. Among authors: kholmanskikh o.
Semin Cancer Biol. 2018 Oct;52(Pt 2):166-177. doi: 10.1016/j.semcancer.2017.11.011. Epub 2017 Nov 21.
Semin Cancer Biol. 2018.
PMID: 29170067
Review.
Item in Clipboard
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma.
Papadouli I, Mueller-Berghaus J, Beuneu C, Ali S, Hofner B, Petavy F, Tzogani K, Miermont A, Norga K, Kholmanskikh O, Leest T, Schuessler-Lenz M, Salmonson T, Gisselbrecht C, Garcia JL, Pignatti F.
Papadouli I, et al. Among authors: kholmanskikh o.
Oncologist. 2020 Oct;25(10):894-902. doi: 10.1634/theoncologist.2019-0646. Epub 2020 Apr 27.
Oncologist. 2020.
PMID: 32339368
Free PMC article.
Review.
Item in Clipboard
Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.
Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.
Kholmanskikh O, et al.
Int J Cancer. 2008 Feb 15;122(4):777-84. doi: 10.1002/ijc.23140.
Int J Cancer. 2008.
PMID: 17957795
Free article.
Item in Clipboard
Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.
Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E.
Kholmanskikh O, et al.
Int J Cancer. 2010 Oct 1;127(7):1625-36. doi: 10.1002/ijc.25182.
Int J Cancer. 2010.
PMID: 20099279
Free article.
Item in Clipboard
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.
Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C, Hayward SD, Fuks F, Boon T, De Plaen E.
Laduron S, et al. Among authors: kholmanskikh o.
Nucleic Acids Res. 2004 Aug 17;32(14):4340-50. doi: 10.1093/nar/gkh735. Print 2004.
Nucleic Acids Res. 2004.
PMID: 15316101
Free PMC article.
Item in Clipboard
Cite
Cite